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ABSTRACT: Enzymes are important biomarkers for molec-
ular diagnostics and targets for the action of drugs. In turn,
inorganic nanoparticles (NPs) are of interest as materials for
biological assays, biosensors, cellular and in vivo imaging
probes, and vectors for drug delivery and theranostics. So how
does an enzyme interact with a NP, and what are the
outcomes of multivalent conjugation of its substrate to a NP?
This invited feature article addresses the current state of the
art in answering this question. Using gold nanoparticles (Au
NPs) and semiconductor quantum dots (QDs) as illustrative
materials, we discuss aspects of enzyme structure−function
and the properties of NP interfaces and surface chemistry that
determine enzyme−NP interactions. These aspects render the
substrate-on-NP conﬁgurations far more complex and heterogeneous than the conventional turnover of discrete substrate
molecules in bulk solution. Special attention is also given to the limitations of a standard kinetic analysis of the enzymatic
turnover of these conﬁgurations, the need for a well-deﬁned model of turnover, and whether a “hopping” model can account for
behaviors such as the apparent acceleration of enzyme activity. A detailed and predictive understanding of how enzymes turn
over multivalent NP-substrate conjugates will require a convergence of many concepts and tools from biochemistry, materials,
and interface science. In turn, this understanding will help to enable rational, optimized, and value-added designs of NP
bioconjugates for biomedical and clinical applications.
■ INTRODUCTION
Nanoparticles (NPs) are a diverse group of colloidal materials
with dimensions between ca. 1 and 100 nm and span a wide
range of properties and applications.1 The properties of
inorganic NPs are often diﬀerent or enhanced versus those of
the analogous bulk materials. For example, gold and other
metallic NPs exhibit strong plasmonic resonances,2 semi-
conductor quantum dots are brightly photoluminescent,3 and
some metal oxides and metal alloys evolve unique magnetic
properties as NPs.4 More general advantages of these materials
include the combination of molecule-like diﬀusion with a surface
area that can be functionalized, as well as large surface area-to-
volume ratios. A focus of research for many inorganic NPs has
been the utilization of their properties to address challenges in
biology and medicine. Examples include but are not limited to
cellular and tissue imaging, biosensing, drug delivery, and
theranostics.2,3,5 There is still much that needs to be learned
before these ambitions can be fully realized, not the least of
which is how interfacial chemistry controls the interactions
between inorganic NPs and biological molecules.
Interfacial chemistry is the principal determinant of the
interactions between inorganic NPs and biomolecules, and thus
the optimization of surface chemistry, such as ligand and
polymer coatings, has been a signiﬁcant endeavor toward
biomedical applications. (Here, the term ligand refers to a
molecule that binds to the inorganic surface of a NP.) The
selection of surface chemistry is not trivial as it ideally addresses
several competing requirements: colloidal stability, hydro-
dynamic size, nonspeciﬁc interactions, and methods for
bioconjugation.6,7 Substantial eﬀort has therefore gone into
the development of coatings that tick these boxes and others
depending on the details of the application. There is a
sometimes-underappreciated correlation between the scope of
applications for a NP material and the ease, reliability, and
overall development of its surface chemistry.
A recurring theme for the surface chemistry of many NP
materials is control over noncovalent interactions with
biomolecules. The most common context is nonspeciﬁc
adsorption or biofouling, where proteins and other biomacro-
molecules tend to be the chief oﬀenders butmolecules of all sizes
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and types have the potential to adsorb.8−13 The functionaliza-
tion of NPs with poly(ethylene glycol) (PEG) and zwitterionic
surface chemistries are common strategies for the prevention of
nonspeciﬁc adsorption,14−16 albeit that this goal is not easy to
achieve. A case in point is that the protein corona that tends to
form around NPs in biological ﬂuids (e.g., blood) and in
physiological environments remains a signiﬁcant challenge in
the translation of NPs from laboratory development to clinical
application.8,17,18 In other contexts, the goal may be an
engineered interaction between a NP and a particular
biomolecule of interest, for example, the cationic functionaliza-
tion of a NP as a vector for gene delivery.19,20 Whether in the
context of this protein corona, engineered interactions, or
adsorption in general, the noncovalent interactions of
biomolecules with colloidal NPs range from low aﬃnity,
dynamic, and reversible to high aﬃnity, static, and irreversible
on the time scale of experiments, with a corresponding range of
eﬀects on biological activity and identity within a system.8,9
Enzymes are especially interesting from the perspective of
noncovalent interactions with colloidal NPs. These catalytic
proteins regulate the rates of myriad biochemical processes and
are some of the most important molecular machines of life. Both
the concentration and the state of an enzyme are important in
determining its biological activity: the former is largely
controlled via expression levels, and the latter is controlled
through various mechanisms, including the proteolytic
activation of proenzymes, the covalent modiﬁcation of enzymes
(e.g., phosphorylation), changes in the oligomerization state,
and binding with small-molecule eﬀectors and endogenous
inhibitors. Enzymes are also important biomarkers for disease
diagnostics (e.g., molecular assays and biosensors) and as targets
for the action of drugs.21−25 These two areas of interest are
shared with NPs, so it follows that NPs are materials of interest
for the detection of enzymes and their activity,26,27 and as
potential vectors for the delivery of drugs that inhibit enzymes or
have their release actuated by enzymes.28,29 Whereas the study
of the adsorption of abundant serum proteins on a NP is mainly
concerned with the downstream fate and function of the NP, the
case of adsorption or other interactions between an enzyme and
a NP necessitates concern about the fate and function of both
the NP and enzyme. What are the eﬀects of a colloidal inorganic
NP and its interfacial chemistry on the activity of an enzyme? Is
it possible to control and design these eﬀects to be advantageous
in applications?
Here, we review the interactions between enzymes and
colloidal inorganic NPs conjugated with their substrates. That is,
substrate-on-NP conﬁgurations with enzyme in bulk solution.
These conﬁgurations are very useful for leveraging the favorable
properties of NPs for the bioanalysis of enzymes. The converse
conﬁguration, which is enzyme-on-NP with a substrate in bulk
solution, has been the topic of a greater number of fundamental
studies aimed at elucidating the interactions between enzymes
and NPs, including eﬀects on catalytic activity and stability.
Many of these studies have been highlighted in recent
reviews.30−32 The emphasis on how the enzyme-on-NP
conﬁguration impacts catalysis is natural given that bioprocess-
ing and manufacturing are prospective applications of these
materials.33,34 Although studies with substrate-on-NP conﬁg-
urations are also numerous, most of these studies have been in
the aforementioned analytical or biomedical diagnostic context:
assays, sensors, and imaging probes for enzymes of biological or
clinical importance. There is also interest in using NP-substrate
conjugates as vectors for enzyme-mediated drug delivery. The
emphasis of study has therefore been function; however, the
optimization of the foregoing applications and the realization of
new opportunities for substrate-on-NP conﬁgurations will
require a detailed understanding of their interfacial chemistry,
their interactions with enzymes, and the corresponding eﬀects
on substrate turnover.
The following sections of this article address progress and
challenges toward a detailed understanding of enzymatic
catalysis associated with substrate-on-NP conﬁgurations. The
scope is limited to “hard” colloidal inorganic NPs, with gold
nanoparticles (Au NPs) and semiconductor quantum dots
(QDs) featured prominently. “Soft” organic NPs, such as those
based on lipids and polymers, are also of interest for applications
of substrate-on-NP conﬁgurations; however, we exclude these
materials from discussion because of their markedly diﬀerent
chemistries and morphologies versus those of inorganic NPs.
The prominence of Au NPs and QDs reﬂects their frequent use
in fundamental studies of enzyme activity toward substrate-on-
NP conﬁgurations, which follows from the reaction tracking
modalities available to these materials, their well-established
chemistry, and their overall breadth of prospective applications
in biology and medicine. We begin by ﬁrst reviewing important
aspects of enzyme structure−function and important features of
the colloidal inorganic NP interface. A rudimentary under-
standing of bothNP and enzyme chemistry is assumed, and both
sections are selective in their content rather than exhaustive. We
then summarize methods for tracking enzyme−substrate
reaction progress and address the use of the Michaelis−Menten
formalism for the analysis of kinetic parameters, as well as
alternative conceptual models and caveats for the interpretation
of experimental data from substrate-on-NP conﬁgurations.
These sections are followed by a review of the recent literature,
organized by the concepts of adsorption, steric eﬀects, interfacial
environment, and the acceleration of substrate turnover. A
putative hopping model of enzyme activity with NP-substrate
conjugates is then critically discussed. To close, we oﬀer a
perspective on how this research will move forward and propose
future opportunities for impact on applications in biology and
medicine. As Figure 1 illustrates, the successful development of
predictive models for the activity of enzymes toward NP-
substrate conjugates will be an important advance toward these
applications and a remarkable convergence of research at the
intersection of biochemistry, materials science, and fundamental
interface science.
■ ENZYME STRUCTURE
An enzyme potentially interacts with both components of a
substrate-on-NP conﬁguration. It is therefore useful to discuss
the structural features of an enzyme that may contribute to
substrate−enzyme and NP−enzyme interactions, which may
occur in parallel.
The active site of an enzyme is its most famous structural
feature. Introductory texts generally conceptualize the remark-
ably selective and eﬃcient catalysis of enzymes through
descriptions of the active site, ﬁrst in terms of Fischer’s “lock-
and-key” model and then as the current “hand-in-glove” or
induced-ﬁt model.35 However, the active site is not necessarily
the most important structural feature of an enzyme in the
context of interactions with NPs. The active site comprises a
relatively small percentage of the total number of amino acid
residues of an enzyme, and the number of residues that directly
engage in the catalytic mechanism is typically even smaller.
Serine proteases, for example, are well known for their catalytic
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triads of aspartate, histidine, and serine residues in the active
site.36 Chymotrypsin is a canonical example of a serine protease
and has ∼245 total amino acid residues, but only ∼20 of these
residues form the main (S1) substrate binding pocket, inclusive
of the triad, and an additional 8 residues form 2 loops near the
binding pocket that also play a role in determining substrate
speciﬁcity.36,37 In addition to representing a small fraction of the
total amino acid residues of an enzyme, the location of the active
site varies between enzymes, with some active sites at the
enzyme surface and others within pockets and clefts, accessible
via one or more channels of up to 2 nm or more in length.38
Given all of the above, enzyme structure other than the active
site is generally expected to predominate interactions with NPs
and other interfaces. Indeed, the nonactive site structure of some
enzymes evolved for the very purpose of interactions with
surfaces.39,40
Structure away from the active site is not necessarily structure
that is independent of the active site because some enzymes have
allosteric sites or exosites.41,42 Both terms refer to binding
interactions at sites topologically distinct from the active site but
with eﬀects that propagate to the active site and aﬀect the
substrate turnover and speciﬁcity. These binding interactions
may, for example, refer to the docking of small-molecule ligands
or macromolecular ligands, dimerization of the enzyme, or
association with a membrane. To illustrate structure away from
the active site and highlight that enzymes have their own surface
chemistry, Figure 2 shows simple ribbon and surface
representations of four serine proteases: chymotrypsin, trypsin,
thrombin, and plasmin. Select structural features and properties
are highlighted.37,43−50 Chymotrypsin and trypsin have
orthogonal substrate speciﬁcities but have largely analogous
structures except for small, but important, diﬀerences between
the main binding pocket and loops.37 Trypsin, thrombin, and
plasmin share some substrate speciﬁcity in vitro but have very
diﬀerent structures away from the active site. For trypsin, few
structural features away from its active site are noteworthy;
however, thrombin has two exosites and is perhaps the best-
characterized example of such an enzyme.51,52 Plasmin has
multiple kringle domains (large disulﬁde-stabilized multiloop
structures).44,53 The exosites of thrombin and the kringle
domains of plasmin(ogen) both bind with various regulators of
their activity (or activation). Given the above, it is reasonably
hypothesized that the similar structures of trypsin and
chymotrypsin will lead to similar interactions with NPs despite
their diﬀerent substrate speciﬁcities. A second hypothesis is that
the distinct structural features of thrombin and plasmin will lead
to quite diﬀerent interactions with a NP versus trypsin, despite
the ability of all three of these serine proteases to hydrolyze a
common substrate by a common mechanism.
As with other proteins,9,54 van der Waals, electrostatic,
hydrogen bonding, and hydrophobic interactions, or some
combination thereof, are the likely driving forces of an
interaction between an enzyme and a NP. Both the surface
chemistry of the NP and its size play a role, the latter
determining the surface area and curvature (if the NP is
approximately spherical). For a given molar concentration of
NPs, more surface area oﬀers more adsorption sites. Curvature is
important because the interactions that lead to enzyme
adsorption strongly depend on the distance and contact area
of interaction, which must increase and decrease, respectively, as
the surface of the NP falls away from a globular enzyme more
quickly with a smaller diameter.8,9,46 For an enzyme, properties
such as its molecular weight, isoelectric point (pI), and solubility
may be useful predictors of interactions and their magnitude but
may also be oversimpliﬁcations because these properties treat
the enzyme structure as homogeneous. In general, higher
molecular weight correlates with more contact area for van der
Waals interactions, pI indicates net charge toward electrostatic
interactions, and lower solubility may portend interactions that
decrease the solvated surface area of an enzyme. What is
obscured by these three parameters is the potential for
orientation and localization of these interactions to distinct
structural features of an enzyme, for example, subunits, domains,
and the aforementioned allosteric sites and exosites. As a
thought experiment, imagine two enzymes with similar pI
values: the ﬁrst enzyme has cationic and anionic residues
distributed uniformly over its surface, and the second enzyme
has anionic residues uniformly distributed over its surface but
has its cationic residues concentrated on only one face. The
second enzyme will have much stronger electrostatic inter-
actions with an anionic NP, which is not predicted by the similar
pI values. Trypsin and thrombin are two enzymes thought to
exhibit this type of diﬀerence in their interactions with anionic
NPs because of the two cationic exosites of thrombin.55
Analogously, enzymes with a scattered versus localized
distribution of hydrophobic residues are anticipated to have
diﬀerent interactions with a NP interface.
Another aspect related to enzyme structure that warrants
mentioning is steric hindrance. The context here is not the
potential role of steric eﬀects in the active site determining
enzyme−substrate speciﬁcity but rather the physical size of
Figure 1.Graphical summary of this article. A detailed understanding of
the turnover of multivalent NP-substrate conjugates by enzymes will
require a convergence of biochemistry, materials, and interface science.
The development of predictive models will signiﬁcantly advance the
applications of these conjugates, including assays, sensors, and imaging
probes, as well as enzyme-mediated drug delivery.
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enzymes and NPs relative to one another and relative to the
substrate. The enzymes discussed in this article range in size
from 23 to 128 kDa or, if modeled as ellipsoids, have
approximate dimensions of 2 nm × 2 nm × 2.5 nm up to 2.5
nm × 2.5 nm × 4 nm. The NPs are approximately spherical with
diameters that range from ∼5 to ∼13 nm. It follows from these
relative sizes that there is the potential for steric hindrance
between the enzyme and NP that limits access to the substrate
conjugated to a NP, particularly if the length of the substrate is
much shorter than the radii of the NP and enzyme, or if the
active site of the enzyme is located within a deep cleft.38
Likewise, there is the potential for steric hindrance that impacts
the ability of van der Waals, electrostatic, and hydrophobic
interactions to occur between speciﬁc regions of an enzyme and
a NP.
The takeaway message is that enzymes have size, surface
chemistry, and caveats with respect to assumptions of
homogeneity. Enzymes, like other proteins, also exhibit features
of colloidal behavior. As discussed next, NPs are conceptually
analogous in these respects. Indeed, the analogy of function-
alizedNPs as proteinmimics has been proposed56 because of the
size and behavioral similarities.
Figure 2. Ribbon and surface diagrams for the comparison of selected structural features between four members of the serine protease family:
chymotrypsin, trypsin, thrombin, and plasmin. The Ser-His-Asp catalytic triads are colored red, the S1 substrate binding pockets are colored green, and
select loops are colored yellow and orange. The loops for chymotrypsin and trypsin are the L1 and L2 loops, which play a role in determining substrate
speciﬁcity. For thrombin, the loops are the 60-loop and the γ-loop, which contribute to substrate binding. Loop-5 is highlighted for plasmin and is most
analogous to the 60-loop for thrombin. In addition, important residues for exosites I and II are highlighted in blue and cyan for thrombin, and the ﬁve
kringle domains are highlighted in various shades of blue for plasmin. Surfaces that are colored according to hydrophobicity and electrostatic potential
are also shown.
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■ NANOPARTICLE INTERFACES
Colloidal Inorganic NPs. It is sometimes overlooked that
the name of a NP material is, at best, a partial and ambiguous
description.57 The name deﬁnes almost nothing about the
number or arrangement of atoms, whereas for a small molecule
such as aspirin (acetylsalicylic acid) the name deﬁnes an exact
number and arrangement of atoms of speciﬁc types. For
example, the “Au NP” nomenclature indicates that gold atoms
are bonded in suﬃcient number to form a particle with
dimensions between ca. 2 and 100 nm. A variant such as “gold
nanorod” indicates something about the shape. “CdSe/ZnS
quantum dot” is more descriptive, indicating composition, a
core/shell structure, and a size where quantum conﬁnement
eﬀects are manifest (ca. 2−10 nm), but is nevertheless
ambiguous with respect to the precise number and arrangement
of atoms. Whereas a pure sample of aspirin is homogeneous, an
arguably pure sample of NPs is inherently heterogeneous,
starting but not ending with distributions of particle sizes and
shapes (i.e., polydispersity). It is likely that the heterogeneity in
size and shape propagates to heterogeneity with respect to the
surface area, facets, and surface structure of each individual
nanocrystal and then further propagates to the organic
functionalization of each nanocrystal surface and the interface
between the NP and the solvent.
Au NPs and QDs are highlighted throughout this review as
two exemplars of colloidal inorganic nanocrystals and are the
materials with which studies relevant to our topic have been
Figure 3. Aspects of the interfacial chemistry of Au NPs and QDs. (A) General structure of a ligand for functionalizing a NP and its organization at the
interface of a NP. The examples of functional groups are not meant to be comprehensive in scope. (B) Cartoon of an idealized spherical 13-nm-
diameter Au NP (left) and two examples of how a real crystal may be faceted (cuboctahedron, middle; icosahedron, right). Chemical structures of
citrate ligand 1, and selected examples of ligands with thiol anchors for tuning the surface chemistry, largely via the distal functionality.62−64 (C)
Cartoons of a wurtzite 3.5-nm-diameter CdSe QD (far left) and a 7-nm-diameter CdSe/ZnS (middle right), both idealized to be spherical, and two
examples of how real QDsmay be faceted (middle left and far right). Facets that are charged (terminated with either Cd2+/Zn2+ or Se2−/S2−) or neutral
(terminated with both metal and chalcogen ions) are highlighted. Chemical structures of selected examples of ligands with thiol and dithiol anchors for
tuning the surface chemistry of QDs.74−81 For 12, the average value of n typically varies from n = 12 to 15. The common names of the ligands shown for
both Au NPs and QDs can be found in the SI.
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most frequently undertaken. Some particular features of the
structures of Au NPs and QDs are summarized in the following
subsections before we return to a more general discussion of
inorganic NP interfaces. Several of the features highlighted with
Au NPs and QDs are also relevant to other inorganic NP
materials, including but not limited to nongold metallic NPs,
lanthanide-based upconversion NPs, and metal oxide and
alloyed magnetic NPs. More detailed information about NP
interfaces can be found in recent reviews.7,58 Figure 3 illustrates
some of the main points in the next subsections, including the
general design and interfacial features of an inorganic NP
functionalized with a ligand coating, cartoons of spherical Au
NPs and QDs, example depictions of how real crystals may be
faceted, and examples of ligand structures for tuning the surface
chemistry of these two types of NPs.
Au NP Interface. Au NPs, analogous to bulk gold crystals,
typically have a face-centered cubic (fcc) lattice structure.59
Although typically approximated as spherical, crystalline AuNPs
tend to be polyhedra in reality, whether Platonic, Archimedean,
or Catalan.7,60 Crystal twinning is not uncommon and leads to
some of these shapes.61 The precise shape of the NP determines
the relative proportions of facets that are {111} and {100}. For
example, an icosahedron has exclusively {111} facets, whereas a
cuboctahedron is a mixture of eight {111} facets and six {100}
facets,7,59 albeit that surface reconstructions are expected.
Common Au NP surface chemistries include citrate ligands,
polymers, and discrete thiol(ate) ligands.6 Citrate can be
convenient to retain from synthesis but is often a poor or
mediocre ligand in many applications because of its weak
binding and tenuous electrostatic colloidal stabilization of the
AuNP. Thiol(ate) ligands with distal hydrophilic groups tend to
be the most common and eﬀective strategy in applications that
require control of surface chemistry. These ligands include both
small molecules and biomacromolecules such as oligonucleo-
tides terminated with a thiol linker. As an example of the former,
the Rotello group has developed an impressive library of small-
molecule ligands for Au NPs with tunable distal functionality
that has been shown to modulate protein−NP interactions.62−64
Pioneered by the Mirkin group, the multivalent functionaliza-
tion of citrate-stabilized Au NPs with oligonucleotides has been
the foundation of several bionanotechnological advances and
the foundation of a proposed class of materials called spherical
nucleic acids.65
Thiols are well known for their strong binding to metallic
gold; however, the precise modes of binding remain under
scrutiny.66−69 The putative binding modes between thiol ligands
and Au NPs are inferred from studies on bulk planar gold
interfaces and with atomically precise gold nanoclusters. The
original model of thiols binding at 3-fold hollow sites on an
unreconstructed planar gold {111} surface to form√3 ×√3R
30° lattices and c(4× 2) superlattices has been challenged by the
observation of monomeric RS−Auad−SR and dimeric RS−
(Auad−SR)2 “staple” binding motifs and Au−SR−Au bridge-site
binding motifs, largely but not exclusively with nanoclus-
ters.66,67,69,70 Experiments suggest that staples are associated
with adatoms and are preferred on {111} facets, whereas bridge
binding may be preferred on {100} facets.68,71,72 The process of
adsorption of thiol ligands on gold surfaces can also induce
surface reconstructions66,70 such that the inorganic component
of the interface is not necessarily static. The complete
implications for Au NPs remain to be determined, but it is
reasonably anticipated that there will be a size- and facet-
dependent distribution of thiol−gold binding motifs.
QD Interface. Like Au NPs, QDs are typically approximated
as spherical but are also polyhedra, with the numbers and types
of facets determined during nanocrystal synthesis.7,58 CdSe is
the prototypical QD material and can adopt both zinc blende
and wurtzite crystal structures. Zinc blende QDs tend to be
tetrahedral or faceted in a way that approximates a sphere, with
the possibility of being isotropic and displaying only one type of
facet, whereas wurtzite QDs tend to be slightly elongated along
their c axis and are multifaceted.58 Ultimately, the shape of the
QD nanocrystal determines the facets displayed, where these
facets can be cationic and terminated with Cd2+ ions with
coordination number 2 or 3, anionic and terminated with Se2−
ions, or neutral and terminated with both Cd2+ and Se2− ions,
albeit that surface reconstructions are expected. Although the
foregoing is written in the context of CdSe QDs, the general
concepts extend to many common core QDmaterials, including
other II−VI semiconductors such as CdS and ZnS, III−V
semiconductors such as InP, IV−VI semiconductors such as
PbS, and epitaxial core/shell QD structures such as CdSe/ZnS.
Hydrophilic QDs are typically functionalized with one of
three general chemistries: discrete ligands that bind to the
inorganic nanocrystal, polymers with pendant groups that bind
to the inorganic nanocrystal, and amphiphilic polymers that
wrap around the nanocrystals and retain hydrophobic ligands
from synthesis.6,73 For studies of enzyme activity toward QD-
substrate conjugates, discrete ligands based on anchoring
thiol(ate) groups and distal hydrophilic groups have been the
most common type of surface functionalization. Figure 3 shows
several examples of thiol ligands, including a family of ligands
based on dihydrolipoic acid (DHLA) and a subset of DHLA-
PEG ligands with various distal functional groups.74−81 Many of
these ligands are from or are inspired by the Medintz and
Mattoussi groups.74−79
The thiol(ate) groups of ligands preferentially bind to cationic
sites on the nanocrystal surface,7,58 and therefore diﬀerent
densities and displays of ligands are anticipated between facets.
In principle, the same ligands can be used to functionalize Au
NPs and QDs; however, the coordinate bonding interactions
between thiol(ate) ligands and cationic sites on the QD surface
are weaker than the corresponding bonding interactions with Au
NPs. This fact accounts, in part, for the predominance of
monothiol ligands with Au NPs and dithiol ligands based on
DHLA with QDs.
Interfacial Heterogeneity. It emerges from the previous
subsections that nanocrystals are not only heterogeneous in size
and shape but also potentially heterogeneous as individual
particles because of their diﬀerent facets. Diﬀerences in
inorganic structure between facets are anticipated to propagate
to diﬀerences in organic ligand displays between facets, with the
ligand numbers and densities being two such examples. These
diﬀerences may have downstream eﬀects as, for example, density
contributes to the frequency of gauche defects, as does the radius
of curvature of a NP.7,82,83 Ligands fan out as the radius of
curvature decreases and thus more space is available to
accommodate gauche defects. With the idea that facets are
locally ﬂat faces of a nanocrystal, the concept of the radius of
curvature translates into the total numbers and size of each facet
and breaks in ligand coverage at edges and vertices between
facets, which accommodate a large amount of structural
disorder. The structural disorder is generally expected to
decrease as the facets grow larger and with features of a ligand
that promote better packing (e.g., longer alkyl chain lengths).
Surface reconstructions induced by ligand adsorption are
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anticipated to add to the diﬀerences between facets, perhaps to
the point that no two facets in an ensemble of NPs are truly
equivalent.
Even more heterogeneity may be encountered in the special
case of core/shell NPs because the epitaxial growth of a uniform
shell is not trivial. The possibility of uneven or incomplete
coverage with shell material, which has been observed with
core/shell QDs,84 brings with it the possibility that diﬀerent
facets have diﬀerent chemical compositions. Likewise, if ligand
exchange is used to apply the ﬁnal organic coating to a NP, then
this process is not necessarily 100% eﬃcient or uniform between
diﬀerent facets85,86 and is another potential source of
heterogeneity in chemical composition between facets.
Yet another source of interfacial heterogeneity is bioconju-
gation, which, for example, is required to attach an enzyme
substrate to a NP. The concepts and challenges of NP
bioconjugation have been reviewed in detail elsewhere.1 For
many chemistries, both the NP and the biomolecule of interest
have multiple potential points of attachment, which generally
results in a population of NP-bioconjugates with broad
distributions in the number of biomolecules per NP and the
orientations of those biomolecules. The tendency of hydrolysis
to compete with many popular bioconjugation reactions
exacerbates the challenge and adds potentially signiﬁcant
batch-to-batch variation. Although some chemistries provide
much better control and reproducibility than others (e.g., the
self-assembly of polyhistidine-tagged and thiol-terminated
biomolecules to QDs and Au NPs, respectively), there are few,
if any, chemistries that enable the conjugation of biomolecules
toQDs and AuNPs in a manner that is homogeneous in number
and attachment point per NP.
There is no all-in-one characterization method for the NP
interface. Instead, an array of methods must be utilized and
cross-referenced, often with great attention to detail to correctly
identify and interpret features in the data.7,87,88 Consequently,
many of the above concepts are not yet directly characterized or
fully understood but rather are inferred from an accumulation of
experiments and observations, or extrapolated from cluster
molecules or related bulk materials.
Sources of Interfacial Variability. To this point,
fundamental materials chemistry has been discussed as a root
cause of heterogeneity. A related challenge is the variability
between preparations of NPs. Although batch-to-batch variation
is also rooted in chemistry, it is not just an outcome of the
nominal identity of the NP material but also an outcome of the
detailed route by which the NP material was attained. Synthesis
factors that are expected to aﬀect the details of a ﬁnal inorganic
NP include the selection of precursors, solvents, and ligands;
impurities; reagent stoichiometry; mixing/stirring eﬃciency;
and temperature, pressure, and pH, among other condi-
tions.89−94 For example, the practical challenge of precisely
regulating high temperatures and reagent impurities in the early
solvothermal synthesis of QDs was (and remains) a considerable
source of variability, as are the conditions of shell growth. In
addition, aqueous and solvothermal methods of synthesis for
compositionally identical QD materials (e.g., CdTe, CdS) do
not tend to yield functionally equivalent materials.
The above arguments regarding reactants and reaction
conditions also extend to surface functionalization methods
such as ligand exchange. Given that ligand adsorption may
induce surface reconstruction, it is not necessarily the case that
the initial inorganic surface is immutable during ligand
exchange. It is thus possible that the combination of methods
for NP synthesis and ligand exchange determines the density,
orientation, and other details of the ﬁnal ligand-functionalized
NP interface.
In addition to all of the above, the aging of inorganic NP
materials is another potential source of heterogeneity. For
example, some NP materials, including QDs, are susceptible to
oxidation and the formation of an oxide layer at their interface.95
Corrosion, etching, and leaching are general degradation
pathways for most metal-based NPs, with the rates of
degradation being dependent on the materials and their
passivation and conditions such as temperature and pH. As an
example, silver NPs are notorious for their poor chemical
stability, which stands in contrast to the comparatively good
stability of AuNPs.96 Ligands are also a potential source of aging
because noncovalent binding makes their oﬀ-rate and
desorption equilibrium important once a functionalized NP is
puriﬁed of excess ligand. The oﬀ-rate and position of a new
equilibrium between free and bound ligand will depend upon
the dilution, the strength of the ligand−NP binding interaction,
and the pH or other conditions that aﬀect that interaction.97,98
The foregoing discussion also extends to conjugated bio-
molecules, which may desorb if bound noncovalently (including
covalent bonding to noncovalently bound NP ligands) and
denature or otherwise degrade over time. Irrespective of material
andmechanism, the rapid, severe degradation of a NPmaterial is
perhaps a minimal source of variability because it is readily
detected. It is slower degradation over days, weeks, or months
with minimal outward symptoms that may be more problematic
over a series of experiments.
Overall, the variability between the ﬁnal NP materials
produced by diﬀerent methods and between batches produced
by the same nominal method is an obstacle to a more detailed
understanding of how NP surface chemistry aﬀects downstream
applications. Thorough, detailed reporting of methods is
essential for published reports, and guidelines for the detailed
characterization of NPs have been proposed to help compare
and reconcile observations between diﬀerent studies and
batches of materials; however, the undertaking is nontrivial,
and most studies tick only some of the boxes.87,99−101
Interfacial Environment. The full interfacial environment
of aNP comprises not only the inorganic nanocrystal surface and
its organic ligands but also conjugated biomolecules (e.g.,
peptides and other enzyme substrates) and local solvent and
solute molecules.
The local volume of solvent generally diﬀers from that of bulk
solution (i.e., far from the NP) as there is a reorganization of
solvent within ∼2 nm of a NP interface.102 This reorganization
varies between anionic and cationic, zwitterionic, and hydro-
philic neutral coatings (e.g., PEG) on a NP, and indeed, the
details of hydration and hydrogen bonding are principal factors
in the nonfouling character of PEG and zwitterionic coat-
ings.103,104 Charge at the NP interface also brings about the well-
known electrical double layer, resulting in a diﬀerent local ionic
strength at the NP interface. The Debye length ranges from less
than 1 nm to several nanometers depending on the bulk ionic
strength.105
Other important considerations at the NP interface arise from
multivalency, which refers to the numbers of ligands and
conjugated biomacromolecules per NP. Nearest-neighbor
interactions occur with some similarity to bulk interfaces but
also with potential diﬀerences from the radius of curvature or
faceting of a NP. As an example of interactions between ligands,
the carboxyl group pKa of monothioalkyl acid ligands is elevated
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on Au NPs and QDs because of hydrogen bonding between
adjacent ligand molecules, mediated in part by the radius of
curvature of theNP.106,107 The same eﬀect does not appear to be
observed with dihydrolipoic acid ligands, presumably because of
diﬀerent organization and density imposed by their dithiol
anchoring group. A high local concentration of conjugated
biomolecules can also induce concentration-dependent pro-
cesses to occur eﬃciently at the interface of a NP even when
ineﬃcient in bulk solution. To illustrate, imagine a NP of
diameter d, conjugated with an average of N peptides per NP,
where a distance of 10 nm from the NP surface is (arbitrarily)
deﬁned as the local environment. Figure 4 plots the
concentration of peptide within this volume depending on the
value of N and the diameter of the NP. The local concentration
varies by 3 orders of magnitude from ∼10 μM to ∼10 mM. One
example of a demonstration of this eﬀect is the self-quenching of
ﬂuorescence fromQD-conjugated, dye-labeled peptides because
of dimerization of the dyes between neighboring peptides.108 No
such behavior was observed without the localization of multiple
copies of the peptide to a QD. This result also suggests the
potential for dimerization or other density-induced interactions
between conjugated biomolecules themselves.
Note that there is a distinction between the concepts of a high
local concentration and high avidity for a NP.54,109 In our
context, eﬀects from a high local concentration are associated
with an increased probability of productive encounters between
an enzyme and substrate at a NP interface, whereas eﬀects from
avidity are associated with multiple, concurrent binding
interactions (e.g., multiple biomolecules conjugated to the
same NP are bound to multiple receptors on a cell membrane).
A single enzyme with a single binding site does not experience
avidity with respect to the NP because it can bind only to a single
substrate molecule at any given time.
Another eﬀect from the multivalent conjugation of bio-
macromolecules to a NP is a reduction in their degrees of
freedom versus the bulk solution because of their anchoring and
interactions (e.g., steric, electrostatic) with the surface of the NP
and between one another, which impacts the range and
dynamics of conformations adopted. For example, oligonucleo-
tides and peptides adopt an average conformation that is more
upright as their number per NP increases.110,111 Moreover, the
radius of curvature of a NP aﬀects the maximum densities of
conjugated biomacromolecules that can be achieved, with
smaller-diameter NPs supporting a smaller number but higher
density because of the greater deﬂection angle between nearest
neighbors.112 The density of biomacromolecules on a NP can
therefore be greater than on a bulk interface.
The next section will review how measurements of the
enzymatic turnover of NP-substrate conjugates aremade, and, in
part, will highlight how conventional analyses overlook or
homogenize much of the detail and heterogeneity discussed in
this section.
■ METHODS AND MODELS
Assay Methods. The most common methods for tracking
enzyme activity toward NP-substrate conjugates are based on
ﬂuorescence. These methods capitalize on the inherent
photoluminescence (PL) properties of QDs and the ﬂuo-
rescence quenching abilities of Au NPs.113 Fluorescence
methods are very useful for tracking enzyme activity because
they are sensitive, multicolor, and, in the cases of Förster
resonance energy transfer (FRET) and electron transfer
quenching, enable real-time tracking without washing or
developing steps. Real-time tracking is also advantageous
because it allows the enzyme−substrate reaction to be followed
with high temporal resolution. Suitable calibration also enables
quantitative measurements. These methods are robust but
nevertheless work best when care is taken to minimize artifacts
from strong light scattering, inner ﬁlter eﬀects, and trivial
radiative energy transfer. The desired data from tracking is a
measure of the substrate or product as a function of timea
partial or full reaction progress curve.
The substrate selected for an assay must concurrently satisfy
the criteria mandated by the speciﬁcity of the enzyme and
support a mechanism of signaling upon its turnover to product.
(See the SI for more discussion.) Dye-labeled substrates are a
common strategy for tracking hydrolase activity with Au NPs
and QDs. For example, dye-labeled peptides are useful for
tracking protease activity.114,115 The dye initially quenches the
QD PL emission intensity via FRET, and peptide hydrolysis is
tracked through the recovery of QD PL as the dye diﬀuses
beyond the range of energy transfer. If this dye is ﬂuorescent,
then the ratio of dye and QD PL emission intensities is another
Figure 4. High local concentration of a substrate around a NP. (A)
Simple model of a NP-[substrate]N conjugate: the NP has a radius r,
and there are N substrates per NP that occupy a local volume that
extends radially 10 nm from the NP surface. The saturation of the NP
surface is based on a footprint of f ≈ 4 nm2 for each substrate. (B) Plot
of the local concentration as a function of NP diameter and the value of
N. Details of the calculation can be found in the SI.
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useful metric for tracking. An analogous format substitutes an Au
NP for the QD, where the ﬂuorescent dye label on a conjugated
peptide is quenched via energy transfer to the Au NP and the
recovery of dye ﬂuorescence emission intensity tracks with the
hydrolysis of the peptide.116 These two formats are equally
applicable to nucleases with the substitution of an oligonucleo-
tide for the peptide117−122 and, in principle, to all types of
hydrolases and their macromolecular substrates. Tracking of
transferase activity is also possible using a similar assay format.
The distinction for transferases is that the enzyme does not
cleave the ﬂuorescent dye from the NP-peptide substrate
conjugate but rather modiﬁes a speciﬁc peptide residue with the
dye, either directly or indirectly.123−125 Direct modiﬁcation is
usually preferable for real-time kinetic measurements. Figure 5
summarizes the foregoing energy-transfer-based assay formats,
which may also prove useful for tracking ligase and lyase activity.
Analogous in concept to the above, there are some cases
where the product itself quenches the QD PL emission via
FRET or electron transfer but the substrate does not (or vice
versa). This format requires that the substrate changes color
upon conversion to product in order to modify the spectral
overlap parameter required for FRET or that it changes its redox
properties in order to modulate quenching by electron
transfer.123,126 These conﬁgurations tend to be most useful
with oxidoreductases.
If FRET and electron-transfer quenching are not practical,
then the tracking of enzymatic activity may, in principle, be
achieved through chromogenic and ﬂuorogenic small mole-
cules127,128 conjugated to NPs as substrates for an enzyme of
interest. Here, the signal for tracking enzyme activity is
independent of the Au NP or QD. These substrates are widely
utilized for general assays of enzyme activity and have frequently
proven useful with enzyme-on-NP conﬁgurations (for example,
refs 129−131) but have not been common with substrate-on-
NP conﬁgurations. There is no fundamental limitation for the
latter as resolving changes in color or ﬂuorescence intensity
versus a background of Au NPs or QDs has been feasible with
enzyme-on-NP conﬁgurations. It is simply that there is little
precedent for this assay format because the use of a chromogen
or ﬂuorogen in parallel with a Au NP or QD is redundant from
the standpoint of detection. Nevertheless, the format may prove
useful as the scope of fundamental studies on substrate-on-NP
conﬁgurations expands to more enzymes with nonmacromo-
lecular substrates.
Returning to FRET assay formats, a potential challenge in
assaying hydrolase activity toward substrate-on-NP conﬁgu-
rations is the nonspeciﬁc adsorption of product on the NP,55,115
typically driven by electrostatic or hydrophobic interactions.
The culprit may be the substrate itself or the dye label that
engages in energy transfer. The result is that the signal for
tracking substrate never goes to zero energy transfer eﬃciency,
which is otherwise expected for complete conversion to product.
Calibration methods to help account for adsorption have been
proposed and are discussed in the next subsection,115,132 but
nonspeciﬁcally adsorbed product fragments remain diﬃcult to
distinguish from a subpopulation of putative substrates that are
inactive or inaccessible.
Another challenge in assays is drift, which may take the form
of drift in instrument response, drift in the chemistry of the NP-
substrate system (e.g., photobleaching or other nonenzymatic
degradation causing a slow change in the measured observable),
and drift in the activity of the enzyme (e.g., denaturation or other
degradation over time). It is important that each of these forms
of drift is evaluated and addressed through control experiments.
A third and occasional challenge in assays is the measurement
of a NP-free, substrate-only control experiment. Either an
altogether diﬀerent method must be used (e.g., a separation
method)55,115,133 or a ﬂuorescent dye or molecular quencher is
introduced to replace the QD or Au NP.121,122 Although there
are good examples of both approaches, neither is trivial. For
example, in our hands, the former approach has been laborious
and required a honed technique to avoid poor precision, and the
latter strategy has been less reliable with peptide substrates than
with oligonucleotide substrates because of a greater propensity
for dye−dye interactions with the dual labeling of a peptide. One
must also consider the possibility that interchanging between
NP and dye alters a property of the substrate (e.g., average
conformation) that convolves with the desired loss of eﬀects
from the NP to alter the apparent enzymatic activity. The
hypothetical use of small-molecule chromogenic or ﬂuorogenic
substrates avoids these potential challenges.
Progress Curves and Michaelis−Menten Analysis. The
data obtained from assays are full or partial reaction progress
curves that represent the rate of conversion of substrate to
product. The raw data is typically in the form of ﬂuorescence
intensity versus time. Obtaining a turnover rate in standard units
(M s−1) requires a calibration to convert the progress curves to a
molar quantity versus time, as detailed in the next subsection.
The reﬂexive kinetic analysis tends to be the Michaelis−Menten
(MM) model for extracting the parameters KM and kcat, the
Michaelis constant and turnover number, respectively, and their
ratio, kcat/KM, which is the speciﬁcity constant. The appeal is that
the MM parameters are the familiar and basic quantitative
language of enzymology; however, as elaborated on below, the
Figure 5. Examples of energy transfer (ET)-based (e.g., FRET, electron
transfer) assay formats for tracking enzymatic activity toward NP-
substrate conjugates. (A) Release of an energy transfer partner from a
NP through cleavage of a labeled substrate by a hydrolase. (B)
Conversion of a label from an energy transfer-active form to an inactive
form (or vice versa, not shown) by an oxidoreductase. (C) Labeling of a
substrate with an energy transfer partner by a transferase. In principle,
assay formats similar to those in panels A and C can be used for tracking
lyase and ligase activity.
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model tries to standardize the results from conﬁgurations that
are nonstandard and assumes homogeneity. The formalism thus
has deﬁciencies for NP-substrate conjugates.
Two methods are principally used to arrive at values for the
MM parameters from progress curves: calculation from initial
rates, per eq 1, or the ﬁtting of full progress curves with the
integrated MM equation, per eq 2. The terms in these equations
are the reaction velocity, v, and the concentrations of substrate
and product, [S] and [P], as a function of time, t, where the
naught subscript denotes an initial value and the t subscript
denotes a value at an arbitrary time point. Equation 3 is the
closed-form solution of eq 2, where W is the Lambert
function.134−137
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TheMMmodel in eqs 1−3 has several implicit assumptions and
guidelines: a large excess of substrate in order to achieve the
Briggs−Haldane or steady-state approximation of d[ES]/dt =
0,138 where ES is the enzyme−substrate complex; the free ligand
condition of [E]0≪ Km; and [S]0≫ 3Km to determine Km and
kcat separately rather than as only the speciﬁcity constant.
136,137
Moreover, the enzyme must be stable over the period of
measurement, the reaction must be irreversible and without
product inhibition, and progress curves for a series of enzyme
concentrations should pass Selwyn’s test and follow a single
trajectory when plotted in enzyme time.139
For eq 1, initial rates can be obtained from tracking over a time
window that corresponds to the initial turnover of substrate
(typically a few percent consumption or less) or from the
mathematical ﬁtting of full progress curves. In the latter case, the
equation for ﬁtting can be empirical and need not be the
integrated MM equation, but eq 1 and eqs 2 and 3 should
ultimately yield the same values for Km and kcat in the absence of
deviations from MM behavior.
Even if the initial rates will be the basis of quantitative analysis,
we recommend the measurement of full progress curves. Almost
every reaction progress curve looks the same in its initial stages:
approximate linearity at short times and negligible substrate
consumption followed by the introduction of modest curvature
at somewhat longer times as the substrate begins to be depleted.
Substantial consumption of substrate is needed to test the
validity of a kinetic model and resolve mechanism diﬀerences.
Figure 6A shows an example of how the measurement of only
the initial portion of the progress curves would completely
obscure two diﬀerent kinetic proﬁles. This mock data is inspired
by a real example (vide infra) where the diﬀerences between the
initial and full progress curves revealed key diﬀerences in the
models of substrate turnover with a NP.133 Of course, it is
obvious in this example that a naıv̈e assumption of the MM
model is inappropriate and that a full progress curve is useful.
There are also more subtle examples, including our ﬁnding that
the turnover of multivalent QD-peptide substrate conjugates by
a protease did not strictly follow the MM model.115 Figure 6B
shows some of this data, where the deviations are the poor ﬁt of
the modeled MM progress curve and the lack of a single
trajectory when the experimental progress curves are plotted in
enzyme time.
In addition to the ﬁt of the data, it is also important to consider
the congruity between the assumptions of the MM model and
the conditions of the experiment. The MM formalism
sometimes presents challenges for substrate-on-NP conﬁgu-
rations because NPs are typically used at submicromolar
concentrations and thus a large excess of substrate over enzyme
may be impractical to achieve. Although there is a reformulation
of the MM formalism for excess enzyme,140,141 the situation is
complicated by the potential for concurrent turnover of multiple
substrates on a NP by multiple enzymes. An alternative
approach that has been adopted with a small excess of substrate
is the determination of the speciﬁcity constant, kcat/Km, as a
single value with the subsequent estimate of Km via the
assumption that kcat is unchanged from assays with substrates
but not with NPs.115,126
Beyond technical challenges, there is a more fundamental
question to answer with respect to the applicability of the MM
model: what does [S] represent for a substrate-on-NP
conﬁguration?
The number of diﬀusing entities in an x M solution of NP-
[substrate]N conjugates (i.e.,N substrates conjugated per NP) is
less than in an equal volume ofNxM solution of substrate alone,
but the number of substrates that can be converted to product is
greater for x M NP-[substrate]N conjugates than for x M
substrate alone (notwithstanding the frequent challenge of
measuring x accurately for samples of NPs). The choice of [S] =
Figure 6. (A) Hypothetical progress curves for the enzymatic turnover
of NP-[substrate]N conjugates with two diﬀerent NP materials and
three enzyme concentrations. Measurement of only (i) the initial rates
does not reveal signiﬁcant diﬀerences between the two NP materials,
whereas the measurement of (ii) full progress curves clearly reveals
diﬀerences. The dashed box in panel ii indicates the region in panel i.
(B) Kinetic data for the turnover of QD-[peptide substrate]13
conjugates by trypsin: (left) standard progress curves for diﬀerent
concentrations of trypsin (0, 1.3−687 nM, scaling by a factor of 2 from
purple to red) and (right) progress curves plotted in enzyme time. The
blue line is the best ﬁt to the MM model. The red line is the MM
prediction from assays of substrate only. The inset shows a close-up of
data early in the progress curves. Reproduced from ref 115. Copyright
2012 American Chemical Society.
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x M or [S] = Nx M becomes important for quantitative
comparisons of Km and kcat between diﬀerent studies and for
comparisons between assays with NP-[substrate]N and substrate
only, where the potential factor of N diﬀerence in these
parameters needs to be explicit lest it aﬀect the conclusions
drawn. As will be detailed in the next section, the proposed
model of turnover for NP-[substrate]N conjugates may also
inﬂuence the choice of [S] = x M or [S] = Nx M. There is a
proposed hopping model where the conjugate undergoes single-
step conversion from NP-[substrate]N to NP-[product]N in an
encounter with enzyme. If this model is accepted, then the
logical interpretation is that [S] = x M and each value of N for
the conjugate represents a unique substrate that, in principle, has
its own values for Km and kcat. In any case, derived values for Km
and kcat are best labeled as “apparent” but have utility for
comparison between diﬀerent multivalent NP-substrate con-
jugates.
Given the above, an MM analysis should not be automatic. Its
use should be accompanied by clear statements of assumptions
and an evaluation of how a change in assumptions would (if at
all) impact the conclusions drawn.
Amore general approach to kinetic analysis is stepping back to
collision theory. There are interpretations of enhancements of
enzyme activity associated with NP-substrate conjugates that
point to parameters such as the collision cross-section and steric
factor,31 and these parameters may be suﬃcient if single-step
conversion of NP-[substrate]N to NP-[product]N is accepted. If
not accepted, modiﬁcations to collision theory should take into
account that multiple productive collisions are needed to
convert all N substrates per NP into product. More detailed
models may also seek to tease apart potential enzyme−substrate
and enzyme−NP interactions and allow for distributions of
values for model parameters that arise from nontrivial
polydispersity or other heterogeneity of a NP sample. A more
detailed look at the mathematics for models based on collision
theory can be found elsewhere,31 and we will later address
conceptual factors for these models in the context of the capacity
for NP-substrate conjugates to accelerate enzymatic activity.
Model Matters. With the questionable applicability of a
simple MM model, other models are needed for the
interpretation of progress curve data. As noted earlier, a hopping
model has been proposed for the enzymatic turnover of NP-
substrate conjugates.55,115,133 In this model, all of the substrate
conjugated to an individual NP is hydrolyzed in a single
encounter with a single enzyme. The putative rate-limiting step
is the diﬀusion of the enzyme between NPs. The opposite
extreme is a model where only one of the conjugated substrates
is hydrolyzed per encounter between an enzyme and the NP,
which we call the “colliding” model.115 For this model, the
putative rate-limiting step is enzyme−substrate binding. Figure
7 illustrates the diﬀerence between these two models in terms of
the time-dependent distribution of the number of substrates per
QD, assuming simple Poisson statistics.142 The colliding model,
which invokes a series of discrete enzyme−substrate inter-
actions, is conceptually most similar to the conventional MM
model, but the hopping model is the most congruent
mathematically. The following paragraphs will illustrate how
the results of a quantitative analysis of experimental data can
depend on the model with which the data is interpreted.
As a thought experiment, consider an assay for protease
activity with QD-[substrate−dye]N conjugates and the use of
FRET for tracking substrate hydrolysis. Figure 8A shows
hypothetical progress curves for this experiment, which are
initially obtained as the QD and dye PL emission intensities
versus time. The dye/QD PL intensity ratio versus time is
calculated from this data and also plotted. The data is modeled
to be ideal with respect to FRET theory and free of noise, drift,
and the nonspeciﬁc adsorption of product. Consequently, the
progress curves for QD PL intensity versus time and the PL ratio
versus time will both yield equivalent results from a full analysis,
albeit the latter is thought to be a more robust metric for real
experiments. To parametrize the thought experiment, we adopt
an initial QD-[substrate−dye]N conjugate with a FRET
eﬃciency of E = 0.75 at N = 10.
First, we consider a colliding model. The calibration for this
model is a series of samples of QD-[substrate]N conjugates
ranging fromN = 0 to 10. Figure 8B shows the model calibration
data. The trend for the QD PL intensity versusN is a hyperbolic
function typical of FRET, and the trend for the dye/QDPL ratio
is linear. The mock data assumes equal quantum yields for the
QD and dye, but the trend in the PL ratio would be linear
Figure 7. Illustrations of the progressive enzymatic turnover of NP-
[substrate]N conjugates according to the (A) colliding model and (B)
hopping model. For each model, cartoon snapshots are shown for the
(sub)populations of NP-substrate/product conjugates at multiple time
points in the reaction as well as the Poisson distribution(s) of the
number of substrates per individual NP, n, for the average values, N.
The reaction time listed for each value of N corresponds to the
hypothetical progress curves in Figure 8.
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regardless of the ratio of quantum yields. The calibration data in
Figure 8B converts the raw data to the stoichiometric progress
curve in Figure 8C. The vertical axis of the progress curves in
Figure 8C includes scales for the ensemble average number of
peptides per QD, N, which is the logical metric for the colliding
model, and for the mole fraction of substrate, calculated as
χsubstrate = N/10 for comparison to the hopping model.
The calibration for a hopping model is a series of samples with
a mixture of QD-[substrate]10 and QD-[substrate]0 conjugates,
with no intermediate values of N, where χsubstrate is the mole
fraction of N = 10 conjugates. (In real experiments, QD-
[product]10 conjugates would be preferred over QD-[sub-
strate]0 conjugates to account for nonspeciﬁc adsorption.) The
trend in the QD PL intensity is linear as a function of χsubstrate,
and the trend in the PL ratio is hyperbolic. The hopping model
calibration data in Figure 8B converts the raw data to the
stoichiometric progress curve in Figure 8C. Note that the
progress curves for the hopping and colliding models are not
superimposed. Rather, the assumption of a colliding model
translates into an apparent faster rate of turnover. The diﬀerence
arises from the requisite diﬀerences in calibration for the
hopping and colliding models. The N and χ parameters are
indeed comparable between the models because each
corresponds to the same number of freely diﬀusing, hydro-
lyzed-product peptide fragments (despite representing a diﬀer-
ent makeup of the NP-substrate conjugates). A quirk is that the
ﬁnal progress curves for the two models become more similar as
the FRET eﬃciency in the initial conjugate decreases and as
nonspeciﬁc adsorption increases. Full details on the analysis of
this thought experiment can be found in the SI.
Of course, there are prospective models that lie between the
extremes of hopping and colliding. The degree to which the real
enzymatic turnover of NP-[substrate]N conjugates approximates
hopping or colliding may depend on the size of the NP and the
value of N. Moreover, if we deﬁne pseudohopping as the
turnover of a large number of substrates per NP per encounter
with enzyme and deﬁne pseudocolliding as the turnover of a
small number of substrates per NP per encounter with enzyme,
then wemust consider the possibilities of each of thesemodels in
isolation and as a mixed model that transitions from
pseudohopping to pseudocolliding as the reaction progresses.
Although the mathematics for these models can be devised,
experiments must ﬁrst establish and parametrize the model that
is most appropriate. It is for this reason that we have recently
stepped back from assigning amodel to our data for the purposes
of extracting apparent values of Km and kcat. Semiquantitative
analysis remains possible without the selection of a colliding,
hopping, or other model by comparing the nonstoichiometric
progress curves with the QD PL intensity or PL ratio plotted
versus time.122,133 The caveat is that the properties of interest of
Figure 8. Thought experiment illustrating two diﬀerent quantitative
results for the same raw FRET assay data: (A) raw datameasured as QD
and dye PL intensity and their ratio versus time; (B) calibration data for
the assumption of colliding and hopping models; and (C) resulting
progress curves. Details of the derivation of the data can be found in the
SI.
Table 1. Overview of Cited Studies on the Turnover of NP-Substrate Conjugates by Enzyme
material surface chemistrya substrate(s) enzyme(s) method(s)b accelerationc ref
Au NP 1, DNA RNA RNase H FQ 1.8×−2.7× 122
QD 12c peptide trypsin FRET 2.8×−4.7× 115
QD 6, 7, 8, 9 peptide trypsin FRET and gels 12×−65× 55
thrombin 1.5×−80×
QD 10 PEG3-Gly-Tyr tyrosinase CTQ 2.3×−3.2× 126
QD 11 peptide collagenase, elastase FRET <1× 143
QD 11, 12a−f peptide trypsin FRET and simulation 3×−35× 79
QD 8, 9, 10, 12c peptide trypsin FRET and gels 3.5×−9× 133
thrombin <1×−5.6×
plasmin 3.6×−5.8×
aThe numbers refer to the structures in Figure 3. bFQ, ﬂuorescence quenching. CTQ, charge-transfer quenching. cFactor by which the turnover of
the NP-[substrate]N conjugate is faster than an equivalent amount of substrate without NP (values >1× indicate acceleration; values <1× indicate
inhibition).
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the conjugate must be varied without substantially changing the
FRET eﬃciency of the initial conjugate, for example, by using a
ﬁxed amount of the dye-labeled substrate and varying only the
surface ligands or identity and number of additional unlabeled
substrates or nonsubstrate biomolecules.133 In real systems, the
FRET eﬃciency generally changes slightly as the system
changes, so small diﬀerences in progress curves must be
interpreted cautiously. Nevertheless, much can still be learned
about how changes in surface chemistry and other properties
impact the turnover of NP-substrate conjugates.
■ ENZYME ACTIVITY AND INTERACTIONS WITH NPS
Overview. The previous sections of this article introduced
concepts of enzymatic activity and interactions with NP-
substrate conjugates apart from actual examples of experimental
studies. We now addmore substance to the discussion through a
review of recent studies that address this research question.
Table 1 summarizes several fundamental studies of the enzyme-
catalyzed turnover of NP-substrate conjugates. (We apologize to
the authors of any studies that we have inadvertently
overlooked.) The results of these studies are distilled into
prevailing factors that aﬀect the rate of NP-substrate conjugate
turnover, each with its own subsection. The ﬁnal subsections
address the recurring observation that the multivalent
conjugation of substrate to a NP appears to accelerate enzyme
activity and assess the current state of the hypothesis that a
hopping model accounts for this acceleration.
Adsorption. A pair of studies that we have completed
indicate an important role for the adsorption of enzyme on a NP
in determining the kinetics of substrate turnover.55,133 The
proteases trypsin, thrombin, and plasmin were used as model
enzymes, and glutathione (GSH, 9 in Figure 3), cysteine (7), 3-
mercaptopropionic acid (MPA, 6), dihydrolipoic acid (DHLA,
8), DHLA-PEG (12), and DHLA-sulfobetaine (DHLA-SB, 10)
were used as surface ligands to functionalize CdSeS/ZnS and
CdSe/CdS/ZnS QDs. The cumulative results of these studies
can be summarized through ﬁve key experiments, as described
below.
First, diﬀerent surface ligand−protease pairings yielded
diﬀerent rates of turnover for X-QD-[peptide substrate]N
conjugates and diﬀerent shapes of progress curves, where X
was one of the cysteine, DHLA, GSH, or MPA surface ligands
and the proteases were trypsin and thrombin.55 The progress
curves were measured via FRET with a distal dye label on the
peptide substrate. There was a general correlation between faster
turnover and progress curves that were one-phase and
convergent to a common end point for diﬀerent protease
concentrations, and between slower turnover and progress
curves that were two-phase and nonconvergent for diﬀerent
protease concentrations. Trypsin exhibited one-phase/conver-
gent progress curves regardless of X, whereas thrombin
exhibited two-phase/nonconvergent progress curves. Even
with the diﬀerent shapes of the progress curve, the same
qualitative trend in the rate of substrate turnover with X was
Figure 9. Protease adsorption aﬀects the turnover of multivalent QD-peptide substrate conjugates. (A) Simpliﬁed cartoon of the conjugates with dye-
labeled peptide substrates for a FRET assay and four diﬀerent surface ligands. Representative progress curves for the turnover of theGSH-QD-[peptide
substrate]10 conjugates by trypsin and plasmin. (E1−E5 are diﬀerent concentrations of enzyme, and C is a control without enzyme.) Trypsin shows
one-phase/convergent progress curves; plasmin shows two-phase/nonconvergent progress curves. The asterisk (*) highlights convergence. (B)
Simpliﬁed cartoon of the conjugates (ligands represented as a mesh shell) with added biomacromolecules and a dye-labeled peptide substrate,
Sub(A647). Representative progress curves for X-QD-[Sub(A647)]10-[Sub]N. The progress curves show an enhancement in the rate or extent of
substrate turnover. (C) Comparison of progress curves with plasmin for X-QD-[peptide substrate]10 conjugates with X = GSH versus DHLA-SB and
DHLA-PEG. DHLA-SB and DHLA-PEG convert the progress curves from two-phase/nonconvergent with GSH to one-phase/convergent. (D)
Agarose gels illustrating the correlation between protease adsorption and kinetics: (i) comparison of trypsin (weaker) and plasmin (stronger)
adsorption on GSH-QD; (ii) DHLA-QD-[peptide]40 conjugates have lower adsorption than QD only (cf. panel i); and (iii) low adsorption of trypsin
on DHLA-SB-QD and DHLA-SB-QD-[peptide]20 conjugates. Adapted from ref 133. Copyright 2017 American Chemical Society.
Langmuir Invited Feature Article
DOI: 10.1021/acs.langmuir.8b02733
Langmuir XXXX, XXX, XXX−XXX
M
observed with both trypsin and thrombin. Subsequent experi-
ments, shown in part in Figure 9A, also revealed two-phase/
nonconvergent progress curves for plasmin with X = DHLA and
GSH.133 The interpretation of the two-phase/nonconvergent
progress curves was that thrombin or plasmin rapidly associated
with X-QD-[peptide substrate]N conjugates, leading to an initial
phase of eﬃcient substrate hydrolysis that then transitioned to a
second phase where the strong adsorption of protease on X-QD
hindered diﬀusion to a new conjugate, causing a marked
decrease in the ensemble rate of hydrolysis. Accordingly, the
interpretation of the one-phase/convergent progress curves was
that, to a ﬁrst approximation, trypsin was free to diﬀuse from
conjugate to conjugate because of weak (if any) adsorption on
the X-QD.
A second set of experiments investigated the eﬀect of X2-QD
on progress curves when mixed with X1-QD-[substrate]N
conjugates, where X1 and X2 are two diﬀerent ligands.
55 The
added X2-QD had the strongest inhibitory eﬀect with the X2 =
MPA and DHLA ligand coatings that were associated with the
slowest turnover of substrate on CdSeS/ZnS QDs by thrombin
and trypsin. In turn, the X2 = GSH and cysteine ligand coatings
that were associated with faster turnover had the smallest
inhibitory eﬀect. Thrombin was much more sensitive to X2-QD
than was trypsin, with the latter exhibiting almost no response to
X2-QD with X2 = GSH and cysteine. These trends were fully
consistent with expectations from the ﬁrst set of experiments,
further supporting the potential eﬀect of the QD interface as an
inhibitor of protease activity, putatively via strong adsorption
and the loss of diﬀusion between conjugates.55
Two additional experiments further addressed surface eﬀects,
this time from the standpoint of surface passivation to reduce
protease adsorption.133 Figure 9B shows an example in which
loading of the QD with an increasing number, M, of other
biomacromolecules yielded an overall trend of increasing rate
(one-phase progress curves) or extent (two-phase progress
curves) of the substrate turnover. These conjugates were of the
form X-QD-[peptide substrate]N-[Y]M, where Y was an
additional substrate peptide, nonsubstrate peptide, protein, or
discrete PEGmolecules. The trend applied to trypsin, thrombin,
and plasmin, albeit that the biggest eﬀects were observed with
plasmin, consistent with it being most prone to adsorption. In
addition, it was found that a change from X = DHLA or GSH to
X = DHLA-SB or DHLA-PEG resulted in a concomitant change
from two-phase/nonconvergent progress curves to one-phase/
convergent progress curves for plasmin activity. This result,
shown in Figure 9C, was consistent with the well-characterized
ability of PEG and zwitterionic coatings on NPs to resist
nonspeciﬁc protein adsorption.14−16 Overall, the two experi-
ments demonstrated that the tuning of surface chemistry can
mitigate inhibitory adsorption and recover protease activity.
The ﬁfth and ﬁnal set of experiments was runs of agarose gel
electrophoresis, which linked all of the foregoing inferences of
adsorption from progress curves to its direct observation.55,133
Examples of gels are shown in Figure 9D. The adsorption of
protease on QDs was observed in several ways: band streaking,
band mobility shifts, the formation of multiple discrete bands of
diﬀerent mobility, and a complete loss of mobility. The order of
these observations approximately trended with increasing
aﬃnity between the QD interface and protein (i.e., lower Kd)
and less dynamic interactions (i.e., slower exchange between
adsorbed and unbound states). Importantly, the gel-derived
trends in protease adsorption on the QDs correlated with trends
in progress curves and substrate turnover between surface
ligands, X, between the three proteases, and with increased
surface passivation from added biomacromolecules, Y. The
caveat was that the protease concentrations at which adsorption
was observed on a gel were higher than the concentrations used
to measure progress curves, but there was a correlation in trends
nonetheless.
A study by Dıáz et al. drew conclusions similar to the
above.143 The activities of elastase and collagenase toward
CdSe/CdZnS/ZnS QDs functionalized with a zwitterionic
ligand (DHLA-CL4) and conjugated dye-labeled peptide
substrate were compared. FRET was again used to measure
progress curves. Diﬀerences between the progress curves for
elastase and collagenase, albeit less than the diﬀerences we
observed between plasmin and thrombin, were attributed to a
much greater tendency for collagenase to adsorb on the QDs,
which was likewise observed as mobility shifts for the QDs in
agarose gel electrophoresis. Greater passivation of the QDs
through conjugation of a greater number of substrate peptides
also increased the rate of substrate turnover.143
The overarching conclusion from the above is that the
minimization of enzyme adsorption on a NP is likely to
maximize the rate of substrate turnover. That said, it remains an
open question as to whether carefully optimized weak and
dynamic adsorption can be more favorable than the complete
and total elimination of adsorption. For example, in cases where
steric hindrance (vide infra) is equal between diﬀerent surface
ligands on a QD, Dıáz et al. have suggested that a weak aﬃnity
between a protease and NP may increase the residence time of
the protease at the NP, potentially facilitating the turnover of
conjugated substrate.79 The aﬃnity between RNase and Au NP-
oligonucleotide conjugates has also been reported to accelerate
nuclease activity.122 Themeans by which weak adsorptionmight
accelerate enzyme activity are discussed later.
Steric Hindrance. In one of our studies,133 we saw a putative
eﬀect of steric hindrance between X = DHLA-SB and DHLA-
PEG for X-QD-[peptide substrate]N conjugates. Although both
ligands engendered one-phase/convergent progress curves with
plasmin (cf. two-phase/nonconvergent progress curves with X =
GSH, DHLA), a much slower rate of substrate turnover was
observed for DHLA-PEG. Both the DHLA-SB and DHLA-PEG
coatings resisted adsorption, so the diﬀerence in rate was
attributed to the much larger size of the DHLA-PEG ligand. A
signiﬁcant portion of the length of the substrate was within the
PEG layer around the QD, representing a potential hindrance
for binding by plasmin.
The above conclusion was in agreement with a contemporary
study by Dıáz et al. that assessed the turnover of X-QD-[peptide
substrate]N conjugates by trypsin, where X was a series of
DHLA-PEG-R ligands (Figure 3C, 12) and R was a variable
functional group at the distal terminus of the PEG chain: amine,
acetyl, methoxy, hydroxyl, carboxyl, or a zwitterionic group
(denoted as CL4).79 ADHLA-CL4 ligand without PEGwas also
evaluated as a control. Substrate turnover was fastest on the
DHLA-CL4-QDs, consistent with steric hindrance from the
PEG chains limiting access to the peptide substrate by trypsin.
Moreover, atomistic molecular dynamics simulations suggested
that there was some correlation between the solvent-accessible
surface area (SASA) and turnover rates between the DHLA-
PEG-R ligands, indicating an important role for steric hindrance
in determining rates of substrate turnover. Figure 10 presents
simple models of the sterically unhindered DHLA-CL4-QD-
[peptide substrate]N conjugate and the hindered DHLA-PEG-
OMe-QD-[peptide substrate]N conjugate as well as outputs of
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the molecular dynamics simulations for SASA and adsorption
energies (vide supra).
Interestingly, the observation of steric hindrance with QD-
[substrate]N conjugates has, to date, been limited to eﬀects from
ligands.With compact ligands onQDs, large numbers of peptide
per QD have not yet been reported to hinder protease activity
versus smaller numbers. The likely explanation is that maximum
peptide valences have been ≤60 per QD, whereas ligand
numbers per QD have been estimated to be >200 per QD.79
Higher densities of ligands are thus a likely factor; however,
diﬀerences in the overall NP solvation for PEG ligands versus
compact ligands and/or a higher aﬃnity of proteases for
peptides versus PEG cannot be ruled out. Co-assembly of
peptide substrates with globular proteins also did not introduce
detectable steric hindrance,133 although there is not yet
suﬃcient data to generalize this result.
In contrast to the above with QDs, there is some indication
that peptides can be conjugated to Au NPs with suﬃcient
density to cause steric hindrance, although these results are also
not yet generalizable. A study by Yeh et al. found that
chymotrypsin-catalyzed hydrolysis rates improved by 5-fold
when the length of a peptide substrate conjugated to Au NPs
increased from 9 residues to 13 residues, moving the cleavage
sites further from the surface of the NP.144 An additional 100-
fold improvement was observed when the ﬁve inserted residues
were converted from neutral to anionic. One explanation for this
marked improvement, proposed by Yeh et al., was that the ﬁve
anionic residues interacted favorably with the halo of cationic
residues around the active site of chymotrypsin. Other possible
explanations are that repulsion between neighboring poly-
anionic peptides (and potentially residual citrate ligands on the
Au NP) caused the peptides to be conjugated at a lower density
and/or adopt a conformation that was more upright relative to
the Au NP surface, alleviating steric hindrance. Moreover, the
Au NPs modiﬁed with 9-mer and neutral 13-mer peptides had
poor colloidal stability and required 0.1% bovine serum albumin
(BSA) in solution as a stabilizer, whereas the Au NP modiﬁed
with the anionic 13-mer probe did not.144 BSA-stabilized
aggregates of the former twoNPmaterials or BSA adsorbed onto
individual Au NPs are potential steric hindrances for
chymotrypsin, and BSA is a potential competitive inhibitor as
a second substrate. The initial 5-fold improvement with the
neutral 13-mer peptide therefore seems attributable to a steric
eﬀect, but the subsequent 100-fold enhancement with the
anionic 13-mer peptide is perhaps ambiguous or more complex
in its origin. Nevertheless, the nature of peptide binding to Au
NPs versus QDs, which is monothiol-gold binding displacing
citrate functionalization versus hexahistidine-ZnS shell binding
with a concomitant dithiol ligand, is such that a higher density of
conjugated peptides should be achievable with Au NPs. Steric
eﬀects from substrate density are therefore more likely to occur
with Au NPs.
Another example of steric hindrance with Au NPs was
observed in assays for the activity of botulinum A light chain
(BoLcA) protease activity.145 The AuNPs were conjugated with
peptide substrates, and turnover was compared between AuNPs
with average diameters of 1.4, 6, and 18 nm. The turnover with
the 6 and 18 nm Au NPs was 80-fold less than with 1.4 nm Au
NPs. In analogous experiments with trypsin, the turnover was
also less with the larger Au NPs but only 18-fold less versus the
1.4 nm Au NP. These diﬀerent sensitivities to the steric eﬀect of
the NP was attributed to the larger size of BoLcA, which was
double the molecular weight of trypsin, as well as its 2.4-nm-
deep active site cleft.145 Presumptive steric eﬀects have also been
observed with BoLcA and QD-peptide conjugates.146
Despite the above examples, steric hindrance is not a foregone
conclusion with a high density of substrate on AuNPs. Prigodich
et al. found that the high density of DNA oligonucleotides
around a NP actually enhanced nuclease binding by a factor of
about 2,121,122 suggesting that there was either no steric
hindrance or that it was overwhelmed by the eﬀect of enhanced
aﬃnity (e.g., high local concentration).
Interfacial Environment. Many enzymes have a pH,
temperature, and other parameters that optimize their activity.
As noted earlier, the environment at the NP interface is diﬀerent
than the environment of bulk solution, so this local environment
Figure 10. Illustration of steric versus adsorption eﬀects for the
turnover of X-QD-[peptide substrate]7−12 conjugates for X = DHLA-
CL4 and X = DHLA-PEG-OMe (abbreviated as CL4 and OMe). (A)
Simple models of the conjugates. (B) Simulation results for the
determination of solvent-accessible surface area (SASA) for the CL4
and OMe ligands. (C) Simulation results for the adsorption of trypsin
on the same surface chemistries. (D) Plots of SASA and interaction
energy (corresponding to panels B and C, respectively) for four
diﬀerent ligands: DHLA-CL4, DHLA-PEG-CL4, DHLA-PEG-OMe,
and DHLA-PEG-NH2. Sterics appeared to be the primary determinant
of kinetics, with adsorption playing a secondary role. Adapted from ref
79. Copyright 2017 American Chemical Society.
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may inﬂuence enzymatic activity toward a NP-substrate
conjugate. One such example, shown in Figure 11, arises with
spherical nucleic acids, which are densely multivalent Au NP-
DNA oligonucleotide conjugates. Compared to DNA alone,
these materials are ca. 4-fold more resistant to hydrolysis by
DNase I because the high local concentration of monovalent
cations at the NP interface inhibits nuclease activity by
displacing divalent cation cofactors from the enzyme.121 This
high concentration of cations arises from countering the
polyanionic character of the oligonucleotides and from a local
inﬂux of anions from osmotic pressure that must be balanced by
additional cations.147 The inhibitory eﬀect decreases with lower
negative charge density on the Au NP and for nucleases that are
engineered to be more tolerant of salt.121
Although relatively few studies have (so far) uncovered an
eﬀect of the local NP environment on enzyme activity toward
substrate-on-NP conﬁgurations, possibilities can be extrapolated
from the converse enzyme-on-NP conﬁgurations because the
substrate−enzyme interaction occurs at the interface between
theNP and bulk solution in both cases. For example, Breger et al.
found that phosphotriesterase activity was enhanced versus bulk
solution when conjugated to a QD, concluding that diﬀerent
solvation at the NP interface increased the rate of product
dissociation from the enzyme, which was known to be slower
than the rate of hydrolysis and thus limiting.130 Another study
postulated that an enhancement in the activity of lipase adsorbed
to Au NPs was from the interface lowering the activation energy
barrier for the formation of the enzyme−substrate complex.129
A caution is that alterations of enzyme activity from the local
environment at the NP interface are not necessarily straightfor-
ward to distinguish from an allosteric or similar eﬀect induced by
contact with the NP or other conjugated biomacromolecules.
This concept is more intuitive for enzyme-on-NP conﬁgurations
but may also be applicable to some NP-substrate conjugates.
Experiments that correlate enzyme activity with changes
induced in the NP interfacial environment by upstream changes
in bulk solution are thus important supporting evidence.
Acceleration of Substrate Turnover. The studies cited
above have shown that many factors can aﬀect enzyme activity
toward NP-substrate conjugates. A feature common to several of
these and other studies is an acceleration of substrate turnover
with NP-substrate conjugates versus equivalent quantities of
enzyme and substrate in bulk solution without NP. Examples
include trypsin, thrombin, and plasmin activity toward QD-
[peptide]N substrates,
55,79,133 RNase H activity toward Au NP-
[oligonucleotide]N conjugates,
122 and tyrosinase activity toward
QD-[tyrosine]N conjugates.
126 The accelerations have been an
approximate doubling of turnover rates at the low end and
between 1 to 2 orders of magnitude at the high end, with each
example listed in Table 1. However, the acceleration of activity is
not universal. It has already been mentioned that the local
environment of a Au NP-oligonucleotide conjugate can inhibit
some nucleases,121 and one study found that DHLA-CL4-QD-
[peptide substrate]N conjugates inhibited the activity of
collagenase and elastase,143 although the same nominal
materials accelerated trypsin activity 35-fold in another
study.79 We have also seen indications that batch-to-batch
variation can yield acceleration or inhibition for nominally
similar materials.148 These examples do not necessarily
challenge the concept of enzymatic acceleration with NP-
[substrate]N conjugates, but once again highlight the complexity
of the systems.
Collision theory for reaction rates is a useful framework for
analyzing the acceleration of enzymatic activity toward NP-
[substrate]N conjugates because, irrespective of a hopping or
colliding model, a change in the kinetics rather than the
thermodynamics of substrate to product conversion is expected.
To begin, consider an x μM concentration of the NP-
[substrate]N conjugate versus an Nx μM concentration of only
substrate, both mixed with E nM of enzyme. The latter scenario
has a greater frequency of collisions if the concepts of collision
cross-section and productive orientation are momentarily
neglected. The NP must therefore increase both of the latter
parameters by a combined factor of greater than N if there is to
Figure 11. Impact of monovalent cation concentration in the interfacial
environment of a multivalent NP-oligonucleotide conjugate on
nuclease activity. (A) Although DNase I has a higher aﬃnity for a Au
NP-DNA conjugate versus an isolated oligonucleotide, the rate of
hydrolysis is slower. (B) Progress curves for the assays illustrated in
panel A. Panels A and B are reproduced from ref 121. Copyright 2009
American Chemical Society. (C) Schematic of a protein-spherical
nucleic acid conjugate (left) and radial proﬁle of monovalent cation
concentration from the center of the protein. A similar proﬁle is
expected for Au NP-[oligonucleotide]N conjugates. Reproduced from
ref 147. Copyright 2018 American Chemical Society.
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be an acceleration of substrate turnover. Starting with the
collision cross-section, the physical size of a NP is typically much
greater than that of a substrate alone and is made larger by
multivalent conjugation of a substrate. For example, a typical
QD-[peptide]N conjugate has a QD in the range of 1.5−4 nm in
radius, and FRET data suggests that peptides extend the radius
by an additional 2 to 3 nm.149,150 The collision cross-section is
clearly much larger for the NP-[substrate]N conjugate than for
an individual substrate molecule, as depicted in Figure 12A. A
rough estimate is between 3-fold and 25-fold larger for the
example of a QD-[peptide]N conjugate. The Stokes−Einstein
equation also indicates that the cross-section for a NP should
increase at a faster rate than its diﬀusion coeﬃcient decreases as
the NP diameter increases.
It is also expected that the likelihood of a productive collision
is higher with a NP-[substrate]N conjugate. First, at the moment
of an initial collision, the NP conjugate will display multiple
substrates in close proximity with diﬀerent orientations relative
to the enzyme. This situation is expected to increase the
probability of a productive mutual orientation between enzyme
and substrate, as depicted in Figure 12B. Second, transient
interactions or migration along a NP surface, or temporary
capture within the hydration shell of the NP-substrate conjugate
(an eﬀect reported with other nanoscale enzymatic systems151),
illustrated in Figure 12C, have the potential to increase the
residence time of the enzyme at the NP, giving it more
opportunity to rotate into a productive orientation and bind to a
substrate molecule. These factors also increase the likelihood
that the enzyme will reassociate with a new substrate molecule
after dissociation from another, as depicted in Figure 12D, as
does the high local concentration of substrate with larger N,
depicted in Figure 12E. These overall concepts inspire the
hypothesis that suﬃciently weak but nonzero adsorption or
another interaction with the NP-[substrate]N conjugate may
lead to an enhancement of turnover, even though moderate or
strong adsorption is inhibitory.
A question that arises is if any of the above modiﬁcations to
the parameters of collision theory represent a real change in the
intrinsic Km and kcat for an enzyme−substrate combination. The
answer depends somewhat on perspective, and we will use the
case of a QD-[peptide]N conjugate to illustrate. If each peptide
molecule is to be a unique substrate, then the presumption is
that there is no enhancement in either Km or kcat and that a good
model must account for the features of the multivalent NP
conﬁguration that lead to acceleration (and perhaps even
tolerate unfavorable changes in Km and kcat from loss of degrees
of freedom or steric eﬀects). However, if the entire conjugate is
to be treated as the substrate, then the acceleration of turnover is
reconciled with new values of Km and kcat, preferably labeled as
apparent values because of the diﬀerent molecular-scale
processes versus the conventional Michaelis−Menten model.
For example, many of the processes depicted in Figure 12
suggest that the apparent value of theMichaelis constant,Km, app,
would, at minimum, be a convolution of the conventional
enzyme−substrate Km and the adsorption constant, Kads, for the
enzyme on theNP.We reserve judgment on which perspective is
most practical until a hopping, colliding, or corresponding
pseudomodel of turnover is conﬁrmed.
In sum, multivalent NP-substrate conjugates have the
potential to yield large accelerations of enzyme activity because
of the high local concentration of substrate at their interface, but
strong adsorption and steric hindrance reduce or negate the
acceleration, and further nuances remain to be determined.
Evidence for a Hopping Model. Much of how to
conceptualize and analyze the enzymatic turnover of NP-
substrate conjugates seems to hinge on the conﬁrmation of a
model for how it occurs, whether hopping or otherwise. The
ideas of a high local concentration of substrate at the NP
interface and weak aﬃnity interactions between the enzyme and
NP-substrate conjugate, discussed in the previous subsection,
are the crux of the rationale for a hopping model of activity. For
many readers, a hopping or pseudohopping model of enzymatic
turnover will seem intuitive for NP-[substrate]N conjugates;
however, to our knowledge, there has yet to be a direct
observation of two discrete populations of NP-[substrate]N and
NP-[product]N that shrink and grow concurrently as the
enzymatic reaction progresses. Rather, evidence has been
indirect, as discussed below.
One of themost compelling bits of evidence is the observation
that the complete turnover of QD-[peptide]N conjugates by
proteases requires an equal or shorter amount of time as N
increases, with N reaching values as high as 60.115,133,143
Analogous results have been observed for increasing N with Au
NP-[oligonucleotide]N conjugates and turnover by nu-
cleases.121,122 If only one or a small number of substrates were
turned over in each encounter, as in colliding and pseudocollid-
ing models, then larger N should require more encounters
between enzyme and NP and therefore a longer time for the
reaction to reach completion. In contrast, a hopping or
pseudohopping model predicts these experimental results. A
potential counterargument posits that larger N progressively
increases the probability of productive encounters and thus
oﬀsets the need for more encounters in a colliding or
pseudocolliding model; however, some observations are not
consistent with this hypothesis. The mobility shifts for QD-
[peptide]N conjugates observed by agarose gel electrophoresis
diminish and become negligible as N increases, such that the
eﬀective size of the conjugates approximately saturates well
before the maximum loading of peptide per QD is reached,133 so
Figure 12. Illustrations of the potential mechanisms through which the
turnover of a substrate is made more eﬃcient by multivalent
conjugation to a NP. (A) The NP-[substrate]N conjugate has a larger
collisional cross-section versus discrete substrate molecules. (B) The
close proximity between multiple substrates increases the likelihood of
a collision with a productive orientation of enzyme. (C) The enzyme
collides with the NP and diﬀuses along its surface to ﬁnd the substrate.
(D) Reversible adsorption to the NP surface facilitates enzyme
reassociation with substrate after dissociation. (E) The close proximity
between multiple substrates facilitates enzyme reassociation with
substrate after dissociation. The importance of each of these
mechanisms is likely to depend on the details of the conjugate.
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a putative larger size cannot account for the steady or increasing
rate of turnover as N continues to increase. Moreover, when N
was kept constant while the density of substrates in Au NP-
[oligonucleotide]N conjugates was decreased by increasing the
eﬀective linker length between the substrate and AuNP, the rate
of turnover by nuclease decreased despite the larger size of the
conjugate.122 The overall results of the above studies suggest
that more substrate per NP increases the frequency with which
intersubstrate hopping occurs, as per Figure 12E.
Other evidence comes from the previously noted real and
predicted adsorption or association of enzyme with NP-
[substrate]N conjugates. Excess components of a NP-[sub-
strate]N conjugate in bulk solution can also act as competitive
inhibitors, as observed for certain surface chemistries of QD
mixed with QD-[peptide]N conjugates and protease,
55 and with
ssDNA mixed with Au NP-[DNA/RNA]N-[ssDNA]M con-
jugates and RNaseH.122 These results suggest that the processes
in Figure 12C−E can occur, as can an analog of the process in
Figure 12E, between inequivalent biomacromolecules. Presum-
ably, the energetics of these processes can be tuned to be either a
contribution to the overall acceleration of enzyme activity or a
deceleration that competes with other accelerating processes in
Figure 12. Although preliminary, this idea is supported by the
aforementioned observation by Dıáz et al. that there was
secondary correlation between observed turnover rates and the
calculated interaction energies between QDs and trypsin.79
Certainly, a hopping mechanism is not unequivocal at this
point and should not be taken as fact; however, the results to
date point in this direction, and the odds for a hopping or
pseudohopping model appear to be better than for a colliding or
pseudocolliding model for some types of multivalent NP-
substrate conjugates.
■ PERSPECTIVE AND CONCLUSIONS
The importance of enzymes as current and future biomarkers
and drug targets is undeniable, andNPs of many kinds have both
well-established and still-developing beneﬁts for biological
detection and targeting. Knowing more about how enzymes
interact with NPs will enable further advancement and
innovation with respect to these application areas. More
fundamental research is needed and must address the complex-
ity of the NP interface and the limitations of current tools for
elucidating its structure and properties.
So what is required to better understand the enzymatic
turnover of NP-substrate conjugates?
One answer is more holistic studies. Taking our work as an
example, we have utilized ensemble FRET assays and gel
electrophoresis supplemented by comparisons to kinetic models
of enzyme activity and simple structural models of
enzymes.55,115,133,148 These methods have been insightful but
homogenized the NP-enzyme systems and only scratched the
surface of their overall complexity. We have also made eﬀorts to
conﬁrm that there is a qualitative persistence of trends across
multiple batches of NPs but have only been able to attribute
quantitative diﬀerences in these trends to undetermined
heterogeneity and batch-to-batch variation. Determining the
root causes of batch-to-batch variation and more general
diﬀerences in behavior between various NP materials and
methods of preparation will require an analysis that is both
multifaceted and detailed:
• Physical characterization of inorganic NPs, including their
distributions of hard size, hydrodynamic size, zeta
potential, and other structural or morphological proper-
ties (e.g., via TEM, DLS, SAXS);
• Chemical characterization of the inorganic and organic
components of functionalized NPs (e.g., via FTIR, NMR,
ICP-MS/OES, XPS, EDX);
• Kinetic models that are tailored to a putative model of
turnover for a NP-substrate conjugate, with clear
deﬁnitions of parameters, assumptions, and limitations;
• Structural models of enzymes, including basic models
with the mapping of surface charges and hydrophobicity,
as well as more advanced models based on molecular
dynamics, energy minimization, and other simulations;
• Broad scope and other steps to establish generality; for
example, experiments with multiple NP materials (e.g.,
diﬀerent composition or size), various preparations and
functionalizations (e.g., series of diﬀerent surface ligands),
replicate batches of the same nominal NP, and multiple
substrates and/or multiple enzymes.
Well-executed holistic studies are undoubtedly a substantial
but worthwhile undertaking for developing a detailed under-
standing of enzymatic activity toward NP-substrate conjugates.
Aside from establishing the generality of results, a broader scope
of experiments will help address domino eﬀects and a hierarchy
of trends. The term “domino eﬀect” refers to a nominal change
in one property that leads to changes in other properties. For
example, a change in the number of macromolecular substrates
per NP has the potential to change not only the local
concentration of substrate but also the average conformation
of those substrates and the steric hindrance for enzyme−NP and
enzyme−substrate interactions. Other potential examples arise
from the aforementioned propagation of changes from one layer
of chemistry to another in the NP-substrate conjugate: a change
in the NP material alters the density of surface ligands, or a
change in the identity of the surface ligand alters the average
conformation of a substrate. A hierarchy of trends will be useful
for parsing domino eﬀects by reliably predicting which of several
possible eﬀects is most important. For example, steric hindrance
may predominate diﬀerences in enzyme activity between two
NP-substrate conjugates with surface ligands of very diﬀerent
molecular weight, whereas the relative aﬃnity of the enzyme
toward the NP may predominate if the surface ligands have
similar molecular weight. The ambition is that it will be possible
to use a small number of discrete factors to predict behavior even
if the real systems are inﬂuenced by a complex continuum of
factors.
Another answer to the question of how to better understand
the enzymatic turnover of NP-substrate conjugates is to shift
away from ensemble methods and toward single-particle
measurements. These measurements avoid the ensemble
averaging that homogenizes a heterogeneous system and are
anticipated to reveal mechanistic details essential to the
modeling of kinetics, including the determination of a hopping,
colliding, or pseudomodel of turnover. Any distinct subpopu-
lations of NPs within an ensemble will also be revealed. A second
useful approach will be separation methods that divide a
heterogeneous ensemble of NPs into semihomogeneous
fractions for enzymatic assays. A comparison of progress curves
or other data for these fractions versus the ensemble, in
combination with a knowledge of the property by which the NPs
were fractionated, will provide insight into correlations between
NP properties and enzymatic activity. In the same vein, high-
throughput and automated methods for the preparation of
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libraries of NP-substrate conjugates and for assays of enzymatic
activity toward these conjugates will enable machine learning
methods for elucidating how various properties aﬀect enzymatic
activity. Machine learning methods have, for example, already
been used for applications in organic synthesis,152−154 materials
development,155,156 prediction of protein−ligand binding,157
and determination of the substrate speciﬁcity of enzymes.158
An expanded role for computational modeling and simulation
is also warranted. There is the potential for this role to go beyond
energy minimization and molecular dynamics modeling of
enzyme−NP interactions at a homogenized interface and
instead address heterogeneity at individual facets, between
subpopulations of NPs in an ensemble, and between NP
identities. These interactions can then be further extrapolated to
simulate substrate turnover and ultimately produce a theoretical
progress curve for an ensemble that can be matched to
experimental data. Inference of mechanistic details then
becomes possible through iterative tweaks of the parameters
of the models until matched to experiments. Moreover,
simulation is perhaps the best available method of extracting
facet-dependent behaviors with NPs. These behaviors are
potentially important, as has recently come to light with bulk
interfacial systems with tethered biomolecules.159
A detailed understanding of enzymatic activity toward NP-
substrate conjugates leads to another question: what beneﬁts
will come from this fundamental knowledge?
In the context of in vitro molecular diagnostics, more sensitive
and more rapid assays of enzyme biomarkers are possible with a
NP-substrate conjugate that optimizes and accelerates enzyme
activity and concurrently resists or slows fouling with a protein
corona in biological ﬂuid. Such a material has substantial value
for point-of-care applications in particular.
Another useful lens through which to view this question is the
control that in vivo biological systems exert over enzyme activity
toward substrates, mirrored against the comparatively poor
substrate speciﬁcity when the same enzymes are used in vitro.
With a detailed understanding of NP−enzyme and substrate−
enzyme interactions, there is the potential for the rational design
of a synthetic conjugate that achieves some of the in vivo
substrate speciﬁcity of an enzyme: for example, a substrate
optimized for the active site of an enzyme (e.g., amino acid
sequence for a protease) in combination with surface chemistry
on the NP that interacts either favorably with the target enzyme
or unfavorably with nontarget enzymes of similar substrate
speciﬁcity. Our observation that the functionalization of a QD
surface with MPA ligands can virtually shut down thrombin
activity but retain trypsin activity is an illustration of this general
concept,55 albeit not suitable for biomedical application.We also
have recent results that show that it is possible to rationally
functionalize a NP to accelerate target enzyme activity rather
than decelerate nontarget enzyme activity.148 This behavior
arose from cofunctionalizing a QDwith a substrate for thrombin
and peptide fragments of a receptor that allosterically interacted
with thrombin to enhance its activity, although it was still
strongly dependent on QD surface chemistry. Facet-dependent
functionalization and interactions with enzymes, coupled with
the synthesis of anisotropic NPs such as plates and rods, may
prove to be yet another route to generating selectivity. Overall,
enhanced speciﬁcity will beneﬁt in vitro assays and cellular and
in vivo imaging probes for fundamental biological research and
clinical application.
A better understanding of enzymatic activity toward NPs also
beneﬁts enzyme-mediated drug delivery and theranostics.160,161
Here, the concept is that a substrate tethers a drug or prodrug
payload to a NP for release via enzymatic activity at the site of
disease. Although organic NPs such as liposomes and polymer
materials predominate NP-mediated drug delivery,162,163
inorganic NPs are also of interest and stand to enable
chemotherapy in combination with other therapies; for example,
Au NPs and iron oxide NPs have prospective application in
photothermal and magnetic hyperthermia therapies, respec-
tively.164−167 In addition, magnetic NPs and lanthanide NPs are
also of interest as contrast agents for imaging.168,169 Current QD
materials are of little interest for clinical drug delivery but are
nonetheless promising as model NP vectors for fundamental
research on drug delivery.170 With aberrant enzyme activity as a
hallmark of many diseases (e.g., kinases and proteases in cancers
and neurodegenerative disease171−175), the control of enzymatic
activity toward NP-substrate conjugates represents a possible
means of controlling the location and rate of drug delivery.
Moreover, there is also the possibility of using NPs as a scaﬀold
for enzyme inhibitors (as many drugs are), analogous to what
has been discussed at length for the NP as a scaﬀold for enzyme
substrates. The high local concentration of inhibitor (or drug) at
the NP interface may increase potency, particularly when
combined with NP surface chemistry that is tailored to be very
favorable and, ideally, somewhat selective for adsorption of the
target enzyme.
To conclude, the activity of enzymes toward NP-substrate
conjugates is an interesting and important avenue of research. A
full understanding of such systems represents a complex and
nuanced problem to solve but will enable important advances in
biomedical research and development and will be another step
toward clinical applications of NPs. Success in solving this
problem will require a concerted eﬀort that leverages a large
variety of tools for colloid and interface science, with several
potential rewards to reap.
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